That is necessary, since the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and work. In other words, we need to understand how these proteins fold if we want a drug to work. Historically, this has actually been an experimental procedure (biotech stocks). But now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're created to do. This was a development almost no one observed. However it's going to have extensive implications for curing disease. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be lots of financial investment opportunities in this space, too. Shifting subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (self-driving cars). That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be surprised if it drew back perhaps significantly before going higher - jeff brown. I've been covering bitcoin for a long time now. One of the first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary recommendation, I titled my report "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time. We were primarily educating readers. But that's not the big concern any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. Mass, Mutual is a trusted 170-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a huge reason I'm bullish on it this year. brownstone research. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These companies raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are a lot of fantastic personal business on the verge of striking the general public markets And I've been working on a brand-new way for you to invest even prior to these companies go public.
This opportunity has been building over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to schedule your spot for free.
Emma Walsh here, handling editor of the Diary. Routine Journal readers know that tech isn't our usual beat (exponential tech investor). And when it pertains to tech investing, we leave it to the professionals. Fortunately, we have a number of such experts in our Rolodex. Our colleague Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing specialists we understand (jeff brown biotech stock pick for 2020). In reality, he had several triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take a look at the big image and forecast what's just around the corner.
That consists of things like 5G networks, biotech, expert system, and much more. These trends are experiencing rapid development and creating amazing opportunities for financiers. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a subject I've been covering for years now. jeff brown genetic sequencer stock. But regardless of what many readers might believe, this is a pattern that's simply starting. Even though the COVID-19 pandemic interfered with supply chains last year, a remarkable 250 million 5G-enabled gadgets were still sold.
And all of this ultimately resulted in Apple postponing the release of the 5G-enabled i, Phone 12 by two months (jeff brown market predictions). Losing two months of manufacturing and sales actually impacts the number of 5G gadgets are sold in the fiscal year. When you think about all of that, offering 250 million systems is impressive. More notably, the hold-ups brought on by the pandemic developed a lots of suppressed demand. And that demand is now going to be pushed into 2021. In truth, I anticipate that more than 500 million 5G gadgets will be shipped in 2021 - united arab emirates. And that's not my only 5G forecast When I have actually discussed 5G in the past, I've described its 3 various stages.
In Stage 2, 5G gadgets go on sale. 5G phones and other products start to reach consumers. And in Phase 3, 5G services start to be provided (jeff brown biotech genome sequencing). That's when we begin to see applications working on 5G networks. Think of things like enormous multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will begin Phase 3 by this summer season. This starts something of a virtuous cycle: A lot of people do not actually care about the technology. However they will care if there are exciting applications that can only be accessed with a 5G phone.
That leads to more 5G apps being established. In truth, 5G is going to open a suite of extraordinary applications: self-driving cars and trucks, the Web of Things, robotic surgical treatment, and more. All of these technologies need 5G. The investment opportunities moving forward will be huge. Stepping away from 5G, the next crucial innovation I predict in 2021 is CRISPR genetic modifying. CRISPR represents "clustered regularly interspaced brief palindromic repeat." It's a mouthful. But it is among the most exciting advancements in biotechnology. At a high level, CRISPR is an innovation that can modify our hereditary makeup as if it were software application.
The program can crash or not operate properly. CRISPR utilizes a comparable concept but with our genetic code. "Typos" in our genome can result in illness. CRISPR can correct these "typos." For several years, CRISPR was primarily a niche innovation that wasn't well comprehended. And throughout that time, there were truly just 3 business running in this area. But things are altering. CRISPR is no longer simply theoretical. We're seeing real results. We're treating illness and seeing that this technology simply works. And as an outcome, a "second crop" of early-stage CRISPR business is going public and delivering incredible returns. This whole industry is successfully a greenfield opportunity.
There's room for many business to exist in this space. jeff brown genome sequencing stock. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that 2 or three more hereditary editing companies will hold their IPOs. Sticking with biotechnology, we are seeing incredible things happening at the convergence of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its most current Alpha, Fold software application can accurately forecast the folding of a protein based exclusively on its amino acid sequence with 92. 4% precision. That's crucial due to the fact that the method a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be effective.
Historically, this has actually been an experimental procedure. Today, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much simpler to develop drugs that do what they're designed to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however a number of drug treatments produced using this innovation. This was among those developments that almost nobody discovered. But it's going to have profound ramifications for curing illness. And, naturally, there will be plenty of investment chances in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be amazed if it drew back perhaps considerably before going higher. I've been covering bitcoin for a long period of time now. One of the first research study reports I ever published was on bitcoin - korean actress. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anybody who followed my suggestion. However at the time of that initial suggestion, I titled my report, "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time.
But nobody is asking that question any longer. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. brownstone research. Mass, Mutual is a 150-year-old institution. So believe about that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more reward forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and declares the details is up to date as of February 2021, but we might not independently validate this claim. Offered Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down a precise figure at this moment. Brown is best known for his sage-like capability to pick winning innovation stocks. He invested more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience provides him an outstanding perspective on the marketplace. He's constantly on the hunt for brand-new chances, and he shares much of his finest picks in the Near Future Report.
That's high appreciation, but it's not absurdly reasoned. Brown has an exceptional track record as a stock-picker, and he effectively forecasted a few of the most significant financial occasions of the previous twenty years. Although he doesn't appear to launch his picks to the public, the service's success is a direct indication of Brown's stock-picking prowess. Nobody on Wall Street gets it ideal each time, but Jeff Brown's accurate forecasts have actually earned him legions of devoted fans. That says a lot about his capability. The Future Report is published by Brownstone Research, a prominent financial research study publisher. Brownstone Research offers a number of research services with a variety of expertises - jeff bezos.
The business is likewise affiliated with Bonner & Partners, another well-respected research publisher - the legacy report prediction. On its website, Brownstone says its mission is to offer retail financiers with professional-grade research study: "For too long, the very best financial investment research study has actually not been available to private financiers. It has been usually booked for investment banks, hedge funds, personal equity, and high-net-worth clients. jeff brown investment prediction. The mission of Brownstone Research study is to make that sort of exclusive research study available to any investors seeking to acquire an edge in the markets. The goal is simple to provide special and successful financial investment research study discovered no place else." -Brownstone Research study website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also serves as the firm's Chief Investment Expert.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to provide its customers. After years of stable success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a family name throughout the majority of America. If you know even a little bit about the market, you know that he has a reputation as a King Midas of sorts. tech stocks. Whatever he touches relies on gold! Jeff is well mindful of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big job.
In fact, Brown believes S.A.V. jeff brown top stock pick 2021. might be "the biggest trend of the 2020s, and he's not alone. Inspect out these quotes from other widely known S.A.V. bulls: Elon's next big act will be marrying two advanced technologies: artificial intelligence and electrical automobiles. Musk hopes the mix will assist him develop the very first fully-autonomous, self-driving cars ever. It's nothing brief of the vehicle market's Holy Grail. As you know, electric vehicles and self-driving vehicle stocks have been huge this year, but the Wall Street maker has approved hype without much tangible outcome. Regardless of an extreme increase in competitors over the previous couple of years, Brown still thinks Musk has the very best chance of putting all of it together.
tech might be the magic string that connects everything together. S.A.V. represents Shared Autonomous Vehicle, and it could be the future of transportation. Essentially, this innovation would allow you to lease out your cars and truck as a self-governing, self-driving taxi when you're not using it. You merely get out of the vehicle and press a button on an app that informs the automobile to "join the fleet." Next thing you understand, you're unwinding on your sofa while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a large piece of the revenues. It sounds insane, but it could be closed than you believe.